Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock
Shares outstanding
263,222,327
Total 13F shares
85,222,099
Share change
-1,712,391
Total reported value
$334,110,423
Put/Call ratio
4.5%
Price per share
$3.92
Number of holders
144
Value change
-$7,128,495
Number of buys
60
Number of sells
63

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAUPOST GROUP LLC/MA
13F
Company
9.3%
24,471,453
$118,442,000 30 Jun 2019
13F
BlackRock Finance, Inc.
13F
Company
3.9%
10,227,592
$49,501,000 30 Jun 2019
13F
STATE STREET CORP
13F
Company
2.2%
5,798,682
$28,066,000 30 Jun 2019
13F
Nantahala Capital Management, LLC
13F
Company
2.2%
5,789,561
$28,021,000 30 Jun 2019
13F
ABRAMS CAPITAL MANAGEMENT, L.P.
13F
Company
2.1%
5,656,462
$27,377,000 30 Jun 2019
13F
VANGUARD GROUP INC
13F
Company
2%
5,169,931
$25,023,000 30 Jun 2019
13F
Novo Holdings A/S
13F
Company
1.2%
3,100,000
$15,004,000 30 Jun 2019
13F
Nuveen Asset Management, LLC
13F
Company
0.62%
1,629,028
$7,885,000 30 Jun 2019
13F
Point72 Asset Management, L.P.
13F
Company
0.62%
1,623,400
$7,857,000 30 Jun 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.57%
1,499,093
$7,255,000 30 Jun 2019
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.57%
1,494,070
$7,231,000 30 Jun 2019
13F
Clearbridge Investments, LLC
13F
Company
0.53%
1,388,328
$6,720,000 30 Jun 2019
13F
MORGAN STANLEY
13F
Company
0.46%
1,208,391
$5,849,000 30 Jun 2019
13F
NORTHERN TRUST CORP
13F
Company
0.44%
1,152,582
$5,578,000 30 Jun 2019
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.4%
1,051,736
$5,090,000 30 Jun 2019
13F
Man Group plc
13F
Company
0.36%
934,650
$4,524,000 30 Jun 2019
13F
NORGES BANK
13F
Company
0.35%
920,031
$4,452,000 30 Jun 2019
13F
Sofinnova Investments, Inc.
13F
Company
0.32%
848,356
$4,106,000 30 Jun 2019
13F
DAFNA Capital Management LLC
13F
Company
0.32%
830,538
$4,020,000 30 Jun 2019
13F
Bank of New York Mellon Corp
13F
Company
0.26%
672,874
$3,256,000 30 Jun 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.25%
648,753
$3,140,000 30 Jun 2019
13F
PKO Investment Management Joint-Stock Co
13F
Company
0.21%
548,376
$2,654,139 30 Jun 2019
13F
D. E. Shaw & Co., Inc.
13F
Company
0.2%
526,592
$2,549,000 30 Jun 2019
13F
Artal Group S.A.
13F
Company
0.16%
425,000
$2,057,000 30 Jun 2019
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.16%
410,358
$1,986,000 30 Jun 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.14%
368,379
$1,783,000 30 Jun 2019
13F
Old West Investment Management, LLC
13F
Company
0.14%
367,870
$1,780,000 30 Jun 2019
13F
CITIGROUP INC
13F
Company
0.13%
341,212
$1,652,000 30 Jun 2019
13F
Stanley-Laman Group, Ltd.
13F
Company
0.12%
312,609
$1,513,000 30 Jun 2019
13F
Deutsche Girozentrale DekaBank
13F
Individual
0.12%
324,200
$1,501,000 30 Jun 2019
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.12%
303,172
$1,467,000 30 Jun 2019
13F
Rafferty Asset Management, LLC
13F
Company
0.11%
299,931
$1,452,000 30 Jun 2019
13F
S.c.a. Candriam
13F
Individual
0.11%
300,000
$1,446,000 30 Jun 2019
13F
Squarepoint Ops LLC
13F
Company
0.11%
285,045
$1,380,000 30 Jun 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.11%
294,813
$1,365,000 30 Jun 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.1%
254,946
$1,234,000 30 Jun 2019
13F
UBS Group AG
13F
Company
0.1%
254,909
$1,234,000 30 Jun 2019
13F
Boston Partners
13F
Company
0.09%
246,266
$1,192,000 30 Jun 2019
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.08%
221,800
$1,074,000 30 Jun 2019
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.08%
199,516
$966,000 30 Jun 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.07%
187,917
$909,000 30 Jun 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.07%
181,765
$880,000 30 Jun 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.07%
176,135
$852,000 30 Jun 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.06%
169,395
$820,000 30 Jun 2019
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
161,199
$780,000 30 Jun 2019
13F
IndexIQ Advisors LLC
13F
Company
0.06%
154,913
$750,000 30 Jun 2019
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.06%
152,461
$738,000 30 Jun 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.06%
149,633
$723,000 30 Jun 2019
13F
FMR LLC
13F
Company
0.06%
145,242
$703,000 30 Jun 2019
13F
Swiss National Bank
13F
Company
0.05%
138,585
$671,000 30 Jun 2019
13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q3 2019

As of 30 Sep 2019, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 144 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,222,099 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BlackRock Inc., Nantahala Capital Management, LLC, ABRAMS CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, STATE STREET CORP, Novo Holdings A/S, Point72 Asset Management, L.P., Nuveen Asset Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 144 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
145
Q3 2019 holders
144
Holder diff
-1
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 Value $ Q3 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.